Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancerWon-Chul Lee, Lixia Diao, Jing Wang, et al.
Journal of Thoracic Disease|July 10, 2020
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancersErin M Corsini, Jinliang Wang, Chia-Chin Wu, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2019
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung CancerHumam Kadara, Smruthy Sivakumar, Yasminka Jakubek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Cancer Research|December 4, 2012
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinomaPierre Saintigny, Erminia Massarelli, Steven Lin, et al.
Nature Cancer|September 28, 2020
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancerShruthy Suresh, BeiBei Chen, Jingfei Zhu, et al.
Cancer Research|May 25, 2016
Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing AirwayYasminka Jakubek, Wenhua Lang, Selina Vattathil, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2022
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironmentNeal Akhave, Jiexin Zhang, Erin Bayley, et al.
Oncotarget|October 20, 2018
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancerDennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, et al.
Pageof 17